The latest malaria news, in 60 seconds.

The FDA’s approval of GSK’s new malaria drug Tafenoquine (Krintafel) provokes a mixed response and a research team from the ANU and The University of Queensland make a ‘small fragment of human protein’ that kills the microbial parasite that causes malaria.

[spreaker type=player resource=”episode_id=15338930″ width=”100%” height=”200px” theme=”light” playlist=”false” playlist-continuous=”false” autoplay=”true” live-autoplay=”false” chapters-image=”true” episode-image-position=”right” hide-logo=”false” hide-likes=”false” hide-comments=”false” hide-sharing=”false” ]

Print Friendly, PDF & Email
Categories: Malaria Minute

Stay Informed

Keep up to date with the latest malaria news.